Interaction between COX-2 G-765C and smoking in relation to coronary artery disease in a Chinese Uighur population
-
Xiang Xie
,
Yi-Ning Yang
Abstract
Background: Coronary artery disease (CAD) is a complex multifactorial and polygenic disorder where multiple environmental and genetic factors are involved simultaneously. The purpose of this study was to explore the relationship between the interaction of cyclooxygenase-2 (COX-2) gene polymorphism and smoking and CAD in a Uighur population.
Methods: Using a case-control study of Chinese Uighur CAD patients (n=430) and healthy controls (n=470), we investigated the roles of G-765C polymorphism in the COX-2 gene (PTGS2) by the use of polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis.
Results: The PTGS2 GG genotype was significantly more prevalent in CAD patients (84.6% vs. 78.3%; p=0.014). Multiple logistic regression analysis showed two independent risk factors: smoking (OR 1.89, 95% CI 1.01–5.24; p=0.008) and hypertension (OR 2.73, 95% CI 1.59–7.21; p=0.001). Moreover, there was a synergistic effect between smoking and the PTGS2 polymorphism and the occurrence of CAD (interaction p=0.009). The odds ratio (OR) estimated by the combined analysis of the PTGS2 GG genotype and smoking history (OR 4.09, 95% CI 2.7–9.3) was markedly higher than that estimated separately from the PTGS2 GG genotype (OR 1.28, 95% CI 0.8–1.9) or smoking (OR 2.51, 95% CI 1.5–5.7) alone. Plasma 6-keto-PGF1α, a stable metabolite of PGI2, was lower in individuals with the PTGS2 GG genotype (p<0.05). Smoking could further lower plasma 6-keto-PGF1α concentrations in GG genotype carriers than non-smokers, especially in patients with CAD.
Conclusions: The PTGS2 polymorphism and smoking were synergistically and significantly associated in Chinese Uighur patients with CAD.
©2011 by Walter de Gruyter Berlin New York
Articles in the same Issue
- Publisher's Note
- Publisher's Note
- Editorials
- Full-Disclosure in Industry-Sponsored Laboratory Medicine Research Studies: Statement by the Consortium of Laboratory Medicine Journal Editors
- Association of malignant mesothelioma and asbestos related conditions with ovarian cancer: shared biomarkers and a possible etiological link?
- Pharmacogenomics of alcohol metabolism: implications for legal testing
- Reviews
- Non-invasive assessment of liver fibrosis: it is time for laboratory medicine
- Application of proteomics to prenatal screening and diagnosis for aneuploidies
- Opinion Paper
- Harmonization of free thyroid hormone tests: a mission impossible?
- Genetics and Molecular Diagnostics
- A polymorphism in the 5’ UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients
- Interaction between COX-2 G-765C and smoking in relation to coronary artery disease in a Chinese Uighur population
- General Clinical Chemistry and Laboratory Medicine
- Serum paraoxonase 1 (PON1) lactonase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after hemodialysis
- Determination of daptomycin in human plasma by liquid chromatography-tandem mass spectrometry. Clinical application
- A high-performance liquid chromatographic method for benznidazole quantitation in plasma of patients with Chagas disease
- Use of serum free light chain analysis and urine protein electrophoresis for detection of monoclonal gammopathies
- Interlaboratory study of free monoclonal immunoglobulin light chain quantification
- Serum zinc-α2-glycoprotein concentrations in patients with non-alcoholic fatty liver disease
- Testosterone is an independent determinant of bone mineral density in men with type 2 diabetes mellitus
- Introduction of a new cobalamin (vitamin B12) assay: lessons from a flawed validation study
- Prevalence and course of pseudothrombocytopenia in outpatients
- Use of the CD19 count in a primary care laboratory as a screening method for B-cell chronic lymphoproliferative disorders in asymptomatic patients with lymphocytosis
- Validation and Outcome Studies Reference Values and Biological Variations
- Age- and gender-dependent changes in circulating concentrations of tumor necrosis factor-α, soluble tumor necrosis factor receptor-1 and sulfated glycosaminoglycan in healthy people
- Gender-specific association of serum uric acid with metabolic syndrome and its components in juvenile obesity
- Cross-sectional study of biomarkers of exposure and biological effect on monozygotic twins discordant for smoking
- Cancer Diagnostics
- Evaluation of ovarian cancer biomarkers in subjects with benign asbestos-related pleural diseases
- Development of a fluorescent microsphere immunoassay for cystatin B (CSTB) in serum of patients with hepatocellular carcinoma
- Letters to the Editor
- Factors reducing hemolysis rates in blood samples from the emergency department
- Low concentrations of serum n-3 polyunsaturated fatty acids in non-alcoholic fatty liver disease patients with liver injury
- Crystal-associated pseudoeosinophilia of synovial fluid
Articles in the same Issue
- Publisher's Note
- Publisher's Note
- Editorials
- Full-Disclosure in Industry-Sponsored Laboratory Medicine Research Studies: Statement by the Consortium of Laboratory Medicine Journal Editors
- Association of malignant mesothelioma and asbestos related conditions with ovarian cancer: shared biomarkers and a possible etiological link?
- Pharmacogenomics of alcohol metabolism: implications for legal testing
- Reviews
- Non-invasive assessment of liver fibrosis: it is time for laboratory medicine
- Application of proteomics to prenatal screening and diagnosis for aneuploidies
- Opinion Paper
- Harmonization of free thyroid hormone tests: a mission impossible?
- Genetics and Molecular Diagnostics
- A polymorphism in the 5’ UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients
- Interaction between COX-2 G-765C and smoking in relation to coronary artery disease in a Chinese Uighur population
- General Clinical Chemistry and Laboratory Medicine
- Serum paraoxonase 1 (PON1) lactonase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after hemodialysis
- Determination of daptomycin in human plasma by liquid chromatography-tandem mass spectrometry. Clinical application
- A high-performance liquid chromatographic method for benznidazole quantitation in plasma of patients with Chagas disease
- Use of serum free light chain analysis and urine protein electrophoresis for detection of monoclonal gammopathies
- Interlaboratory study of free monoclonal immunoglobulin light chain quantification
- Serum zinc-α2-glycoprotein concentrations in patients with non-alcoholic fatty liver disease
- Testosterone is an independent determinant of bone mineral density in men with type 2 diabetes mellitus
- Introduction of a new cobalamin (vitamin B12) assay: lessons from a flawed validation study
- Prevalence and course of pseudothrombocytopenia in outpatients
- Use of the CD19 count in a primary care laboratory as a screening method for B-cell chronic lymphoproliferative disorders in asymptomatic patients with lymphocytosis
- Validation and Outcome Studies Reference Values and Biological Variations
- Age- and gender-dependent changes in circulating concentrations of tumor necrosis factor-α, soluble tumor necrosis factor receptor-1 and sulfated glycosaminoglycan in healthy people
- Gender-specific association of serum uric acid with metabolic syndrome and its components in juvenile obesity
- Cross-sectional study of biomarkers of exposure and biological effect on monozygotic twins discordant for smoking
- Cancer Diagnostics
- Evaluation of ovarian cancer biomarkers in subjects with benign asbestos-related pleural diseases
- Development of a fluorescent microsphere immunoassay for cystatin B (CSTB) in serum of patients with hepatocellular carcinoma
- Letters to the Editor
- Factors reducing hemolysis rates in blood samples from the emergency department
- Low concentrations of serum n-3 polyunsaturated fatty acids in non-alcoholic fatty liver disease patients with liver injury
- Crystal-associated pseudoeosinophilia of synovial fluid
